Stroke Trial, Recruiting (NCT07643337)

Stroke Trial, Recruiting NCT07643337 Sponsor: State University of New York at Buffalo Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07643337 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been approved to receive Vagus Nerve Stimulation (VNS) — a type of nerve therapy — along with rehabilitation treatment
You are between 22 and 80 years old
You have chosen to have VNS therapy specifically to help with arm and hand weakness caused by a stroke
You still have some ability to move your thumb and at least two other fingers on the arm affected by your stroke
Your stroke has also affected your legs and the way you walk, but you can walk at least some distance on your own (confirm with trial site)
You are able to understand and follow simple instructions, and can walk short distances on your own — with or without a walking aid or leg brace — but without someone physically holding or supporting you

Who may not be able to join:

Your leg and lower limb movement is fully intact with no stroke-related weakness (confirm with trial site)
You are not considered a suitable candidate for VNS therapy based on guidelines set by the FDA (the US medical regulatory body)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Assaf Berger, MD, University at Buffalo

Phone: 716-218-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07643337

Sponsor: State University of New York at Buffalo

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: 716-218-1000

More information: https://clinicaltrials.gov/study/NCT07643337

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been approved to receive Vagus Nerve Stimulation (VNS) — a type of nerve therapy — along with rehabilitation treatment
You are between 22 and 80 years old
You have chosen to have VNS therapy specifically to help with arm and hand weakness caused by a stroke
You still have some ability to move your thumb and at least two other fingers on the arm affected by your stroke
Your stroke has also affected your legs and the way you walk, but you can walk at least some distance on your own (confirm with trial site)
You are able to understand and follow simple instructions, and can walk short distances on your own — with or without a walking aid or leg brace — but without someone physically holding or supporting you

Who may not be able to join:

Your leg and lower limb movement is fully intact with no stroke-related weakness (confirm with trial site)
You are not considered a suitable candidate for VNS therapy based on guidelines set by the FDA (the US medical regulatory body)
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

State University of New York at Buffalo

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

15 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Absolute Change in Functional Assessment - Fugl-Meyer Lower Extremity (FMA-LE) scale; Percent Change in Functional Assessment - Fugl-Meyer Lower Extremity (FMA-LE) scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov